EARNEST Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-74
| Closed | -$6.55K | – | 393 |
|
|
2023
Q3 | $6.55K | Hold |
74
| – | – | ﹤0.01% | 727 |
|
|
2023
Q2 | $6.41K | Hold |
74
| – | – | ﹤0.01% | 737 |
|
|
2023
Q1 | $7.2K | Hold |
74
| – | – | ﹤0.01% | 694 |
|
|
2022
Q4 | $7.66K | Hold |
74
| – | – | ﹤0.01% | 675 |
|
|
2022
Q3 | $6K | Hold |
74
| – | – | ﹤0.01% | 704 |
|
|
2022
Q2 | $6K | Hold |
74
| – | – | ﹤0.01% | 728 |
|
|
2022
Q1 | $6K | Hold |
74
| – | – | ﹤0.01% | 770 |
|
|
2021
Q4 | $7K | Hold |
74
| – | – | ﹤0.01% | 757 |
|
|
2021
Q3 | $6K | Hold |
74
| – | – | ﹤0.01% | 781 |
|
|
2021
Q2 | $6K | Hold |
74
| – | – | ﹤0.01% | 788 |
|
|
2021
Q1 | $6K | Hold |
74
| – | – | ﹤0.01% | 762 |
|
|
2020
Q4 | $6K | Hold |
74
| – | – | ﹤0.01% | 745 |
|
|
2020
Q3 | $6K | Hold |
74
| – | – | ﹤0.01% | 686 |
|
|
2020
Q2 | $9K | Hold |
74
| – | – | ﹤0.01% | 581 |
|
|
2020
Q1 | $6K | Hold |
74
| – | – | ﹤0.01% | 610 |
|
|
2019
Q4 | $6K | Hold |
74
| – | – | ﹤0.01% | 699 |
|
|
2019
Q3 | $5K | Hold |
74
| – | – | ﹤0.01% | 732 |
|
|
2019
Q2 | $6K | Hold |
74
| – | – | ﹤0.01% | 693 |
|
|
2019
Q1 | $7K | Hold |
74
| – | – | ﹤0.01% | 641 |
|
|
2018
Q4 | $6K | Hold |
74
| – | – | ﹤0.01% | 649 |
|
|
2018
Q3 | $7K | Hold |
74
| – | – | ﹤0.01% | 654 |
|
|
2018
Q2 | $7K | Hold |
74
| – | – | ﹤0.01% | 649 |
|
|
2018
Q1 | $6K | Hold |
74
| – | – | ﹤0.01% | 672 |
|
|
2017
Q4 | $7K | Buy |
+74
| New | +$7K | ﹤0.01% | 627 |
|
|
2017
Q1 | – | Sell |
-74
| Closed | -$6K | – | 330 |
|
|
2016
Q4 | $6K | Buy |
+74
| New | +$6K | ﹤0.01% | 622 |
|